CN115553470A - Antioxidant hydrogen-rich nutrient element supplement and application thereof - Google Patents
Antioxidant hydrogen-rich nutrient element supplement and application thereof Download PDFInfo
- Publication number
- CN115553470A CN115553470A CN202211157750.0A CN202211157750A CN115553470A CN 115553470 A CN115553470 A CN 115553470A CN 202211157750 A CN202211157750 A CN 202211157750A CN 115553470 A CN115553470 A CN 115553470A
- Authority
- CN
- China
- Prior art keywords
- hydrogen
- antioxidant
- rich nutrient
- supplement
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title claims abstract description 100
- 239000001257 hydrogen Substances 0.000 title claims abstract description 100
- 229910052739 hydrogen Inorganic materials 0.000 title claims abstract description 100
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 61
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 59
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 31
- 239000013589 supplement Substances 0.000 title claims abstract description 29
- 229910052751 metal Inorganic materials 0.000 claims abstract description 32
- 239000002184 metal Substances 0.000 claims abstract description 29
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000463 material Substances 0.000 claims abstract description 23
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000011701 zinc Substances 0.000 claims abstract description 15
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 15
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 11
- 239000011777 magnesium Substances 0.000 claims abstract description 11
- 229910052742 iron Inorganic materials 0.000 claims abstract description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 8
- 239000011575 calcium Substances 0.000 claims abstract description 8
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004411 aluminium Substances 0.000 claims abstract description 6
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000013305 food Nutrition 0.000 claims abstract description 6
- 229910052744 lithium Inorganic materials 0.000 claims abstract description 6
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims abstract description 6
- 229910052712 strontium Inorganic materials 0.000 claims abstract description 6
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 54
- 239000003826 tablet Substances 0.000 claims description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- 235000015872 dietary supplement Nutrition 0.000 claims description 21
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 20
- 229920002472 Starch Polymers 0.000 claims description 13
- 239000008107 starch Substances 0.000 claims description 13
- 235000019698 starch Nutrition 0.000 claims description 13
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- 235000010323 ascorbic acid Nutrition 0.000 claims description 10
- 239000011668 ascorbic acid Substances 0.000 claims description 10
- 229960005070 ascorbic acid Drugs 0.000 claims description 10
- 239000000945 filler Substances 0.000 claims description 10
- 239000000314 lubricant Substances 0.000 claims description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 10
- 239000007884 disintegrant Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 8
- 235000015165 citric acid Nutrition 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 7
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 7
- 239000008116 calcium stearate Substances 0.000 claims description 7
- 235000013539 calcium stearate Nutrition 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 6
- 235000003599 food sweetener Nutrition 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- 239000003765 sweetening agent Substances 0.000 claims description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 239000001630 malic acid Substances 0.000 claims description 5
- 235000011090 malic acid Nutrition 0.000 claims description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 5
- 229960004889 salicylic acid Drugs 0.000 claims description 5
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 239000000174 gluconic acid Substances 0.000 claims description 4
- 235000012208 gluconic acid Nutrition 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 4
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 4
- 229960005055 sodium ascorbate Drugs 0.000 claims description 4
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 239000000454 talc Substances 0.000 claims description 4
- 229910052623 talc Inorganic materials 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002785 Croscarmellose sodium Polymers 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 3
- 239000004260 Potassium ascorbate Substances 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 229960001681 croscarmellose sodium Drugs 0.000 claims description 3
- 229960000913 crospovidone Drugs 0.000 claims description 3
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000001530 fumaric acid Substances 0.000 claims description 3
- 235000011087 fumaric acid Nutrition 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 3
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims description 3
- 229940037627 magnesium lauryl sulfate Drugs 0.000 claims description 3
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 3
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 3
- 235000019275 potassium ascorbate Nutrition 0.000 claims description 3
- 229940017794 potassium ascorbate Drugs 0.000 claims description 3
- CONVKSGEGAVTMB-RXSVEWSESA-M potassium-L-ascorbate Chemical compound [K+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CONVKSGEGAVTMB-RXSVEWSESA-M 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- 229940032147 starch Drugs 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- -1 fortifiers Substances 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 11
- 230000036541 health Effects 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 239000000126 substance Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 150000005846 sugar alcohols Chemical class 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 229920002774 Maltodextrin Polymers 0.000 description 6
- 239000005913 Maltodextrin Substances 0.000 description 6
- 150000002431 hydrogen Chemical class 0.000 description 6
- 229940035034 maltodextrin Drugs 0.000 description 6
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 4
- 229920000858 Cyclodextrin Polymers 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 4
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 4
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 239000000905 isomalt Substances 0.000 description 4
- 235000010439 isomalt Nutrition 0.000 description 4
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 229960001855 mannitol Drugs 0.000 description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000811 xylitol Substances 0.000 description 4
- 235000010447 xylitol Nutrition 0.000 description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 4
- 229960002675 xylitol Drugs 0.000 description 4
- 238000001514 detection method Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical group C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229910012375 magnesium hydride Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009933 reproductive health Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the field of health-care food, in particular to an antioxidant hydrogen-rich nutrient element supplement and application thereof. The invention provides an antioxidant hydrogen-rich nutrient element supplement which comprises the following components in percentage by mass: 1 part of metal and 1-10000 parts of auxiliary materials; the metal comprises one or more of calcium, magnesium, zinc, iron, strontium, manganese, aluminium and lithium. The antioxidant hydrogen-rich nutrient element supplement provided by the invention can provide sufficient hydrogen for a human body and can provide metal elements required by the human body. Particularly, the antioxidant hydrogen-rich nutrient element supplement continuously generates hydrogen in the stomach, so that the problem of low hydrogen concentration of most products in the current market is solved, and an excellent antioxidant effect can be achieved; the intake of important metal nutrient elements can improve the health condition of human body while taking hydrogen.
Description
Technical Field
The invention relates to the field of health-care food, in particular to an antioxidant hydrogen-rich nutrient element supplement and application thereof.
Background
Hydrogen is composed of hydrogen molecules, which are the molecules with the smallest molecular weight and the simplest molecular structure in nature. The hydrogen has extremely strong penetrability, is easy to penetrate the skin and the mucous membrane to enter cells, cell nucleuses and mitochondria, and is easy to be absorbed and utilized by the human body. The hydrogen has an anti-oxidation effect, can efficiently remove malignant free radicals, maintain the internal environment balance of the body fluid inside and outside the cell, and keep effective immunity and self-repairing capability; but also can improve allergic constitution and play a good role in losing weight; meanwhile, researches prove that the hydrogen can improve the insulin secretion function, regulate glycolipid metabolism, reduce blood sugar, improve microcirculation, reduce eyeground pathological changes of diabetes, prevent and treat skin ulcer and the like caused by the diabetes.
Currently, hydrogen intake is generally achieved by drinking hydrogen rich water. Among them, products such as hydrogen water rods, hydrogen-rich water machines (electrolytic or filter element type) and bottled/bagged hydrogen-rich water store hydrogen in water, while hydrogen molecules are easy to escape, and even if the products are packaged and stored in a better way, the hydrogen has the possibility of slow leakage, so that the hydrogen in the products is not easy to store. Meanwhile, the hydrogen concentration of hydrogen-rich water prepared by most of products is below 1.4ppm, and sufficient hydrogen is difficult to supplement at one time.
The main component of the existing solid hydrogen-rich water is calcium hydride or magnesium hydride, which generates hydrogen when meeting water after being orally taken into the stomach. Calcium hydride or magnesium hydride is not stable enough in nature and has a certain toxicity, and therefore, is not an optimal choice. Therefore, there is a need for a product that can provide sufficient hydrogen gas.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides an antioxidant hydrogen-rich nutrient element supplement and application thereof.
In order to solve the above problems, the present invention provides the following technical solutions:
the invention aims to provide an antioxidant hydrogen-rich nutrient element supplement which comprises the following components in percentage by mass: 1 part of metal and 1-10000 parts of auxiliary materials;
the metal comprises one or more of calcium, magnesium, zinc, iron, strontium, manganese, aluminium and lithium.
Preferably, the auxiliary materials include one or more of antioxidants, fortifiers, fillers, flavors, colors and sweeteners.
Preferably, the antioxidant comprises one or more of ascorbic acid, sodium ascorbate and potassium ascorbate.
Preferably, the fortifier comprises one or more of citric acid, malic acid, fumaric acid, succinic acid, tartaric acid, salicylic acid, gluconic acid and amino acids.
Preferably, the filler is one or more of starch, dextrin, sucrose, maltose, glucose, sugar alcohol, microcrystalline cellulose and lactose.
Preferably, the dosage form of the antioxidant hydrogen-rich nutrient supplement is powder, granules or tablets.
Preferably, when the dosage form of the antioxidant hydrogen-rich nutrient supplement is granules or tablets, the auxiliary materials further comprise a disintegrant and/or a lubricant.
Preferably, the disintegrant comprises one or more of dry starch, sodium carboxymethyl starch, hydroxypropyl cellulose, crospovidone, and croscarmellose sodium.
Preferably, the lubricant comprises one or more of stearic acid, magnesium stearate, calcium stearate, sodium lauryl sulfate, powdered silica gel, talc, hydrogenated vegetable oil, polyethylene glycols and magnesium lauryl sulfate.
The invention also provides application of the antioxidant hydrogen-rich nutrient element supplement in the technical scheme in the field of food or medicines.
The invention provides an antioxidant hydrogen-rich nutrient element supplement which comprises the following components in percentage by mass: 1 part of metal and 1-10000 parts of auxiliary materials; the metal comprises one or more of calcium, magnesium, zinc, iron, strontium, manganese, aluminium and lithium. The antioxidant hydrogen-rich nutrient element supplement provided by the invention can provide sufficient hydrogen for a human body and can provide metal elements required by the human body. Particularly, the antioxidant hydrogen-rich nutrient element supplement continuously generates hydrogen in the stomach, so that the problem of low hydrogen concentration of most products in the current market is solved, and an excellent antioxidant effect can be achieved; the intake of important metal nutrient elements can improve the health condition of human body while taking hydrogen.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the experimental methods required in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only used for illustrating the experimental methods in some embodiments of the present invention. For a person skilled in the art, other figures can also be obtained from these figures without inventive exercise.
Fig. 1 is a schematic view of a hydrogen gas production and collection device according to an embodiment of the present disclosure.
Detailed Description
The invention provides an antioxidant hydrogen-rich nutrient element supplement which comprises the following components in percentage by mass: 1 part of metal and 1-10000 parts of auxiliary materials;
the metal comprises one or more of calcium, magnesium, zinc, iron, strontium, manganese, aluminium and lithium.
In the present invention, all the raw material components are commercially available products well known to those skilled in the art, unless otherwise specified.
The antioxidant hydrogen-rich nutrient element supplement comprises 1 part of metal in parts by mass; the metal comprises one or more of calcium, magnesium, zinc, iron, strontium, manganese, aluminium and lithium, preferably one or more of calcium, magnesium, zinc and iron, more preferably one or more of calcium, magnesium and zinc. When the metal is more than two of the specific choices, the proportion of the specific materials is not limited in any way, and the specific materials can be mixed according to any proportion. In an embodiment of the invention, the metals are in particular magnesium, iron and zinc in a mass ratio of 9:1 and iron and zinc in a mass ratio of 1:9. In the present invention, the metal is preferably a metal powder; the particle size of the metal powder is preferably 0.001 to 1000. Mu.m, more preferably 0.01 to 100. Mu.m, and most preferably 0.1 to 80 μm.
In the invention, the metal has the function of generating hydrogen by reacting with gastric acid after being taken, and simultaneously supplementing hydrogen and metal trace elements for human bodies.
Based on the mass parts of the metal, the antioxidant hydrogen-rich nutrient element supplement comprises 1-10000 parts of auxiliary materials, preferably 10-1000 parts. In the present invention, the auxiliary material preferably comprises one or more of an antioxidant, an enhancer, a filler, a flavor, a pigment and a sweetener, more preferably comprises one or more of an antioxidant, an enhancer and a filler, and most preferably comprises an antioxidant and/or a filler. When the auxiliary materials are two or more of the above specific choices, the present invention does not have any special limitation on the ratio of the specific materials, and the ratio of the auxiliary materials can be determined according to the ratio well known to those skilled in the art.
In the present invention, the antioxidant preferably comprises one or more of ascorbic acid, sodium ascorbate and potassium ascorbate, more preferably comprises one or more of ascorbic acid and sodium ascorbate, most preferably ascorbic acid. When the antioxidant is more than two of the above specific choices, the invention does not have any special limitation on the proportion of the specific substances, and the specific substances can be mixed according to any proportion. In an embodiment of the invention, the antioxidant is in particular ascorbic acid.
In the invention, the antioxidant has the functions of preventing metal oxidation, avoiding an oxidation layer from hindering the reaction and fully generating hydrogen.
In the present invention, the fortifier preferably comprises one or more of citric acid, malic acid, fumaric acid, succinic acid, tartaric acid, salicylic acid, gluconic acid and amino acids, more preferably comprises one or more of citric acid, malic acid, salicylic acid, gluconic acid and amino acids, and most preferably comprises one or more of citric acid, malic acid and salicylic acid. When the reinforcers are more than two of the specific choices, the proportion of the specific substances is not limited in any way, and the specific substances are mixed according to any proportion. In an embodiment of the present invention, the enhancer is specifically citric acid.
In the invention, the enhancer is used for enhancing the reaction of the antioxidant hydrogen-rich nutrient element supplement in a gastric acid environment, and hydrogen can be better generated even in an environment with insufficient gastric acid.
In the present invention, the filler is preferably one or more of starch, dextrin, sucrose, maltose, glucose, microcrystalline cellulose and lactose, more preferably one or more of dextrin, sucrose, sugar alcohol, microcrystalline cellulose and lactose, and most preferably one or more of dextrin, sugar alcohol and lactose. When the fillers are more than two of the specific choices, the proportion of the specific materials is not limited in any way, and the specific materials can be mixed according to any proportion. In the present invention, the dextrin preferably comprises maltodextrin and/or cyclodextrin; the cyclodextrin preferably comprises one or more of alpha-cyclodextrin, beta-cyclodextrin and gamma-cyclodextrin. When the dextrin is more than two of the specific choices, the specific proportion of the specific substances is not limited in any way, and the specific substances can be mixed according to any proportion. In an embodiment of the invention, the filler is in particular maltodextrin or alpha-cyclodextrin and maltodextrin in a mass ratio of 2:1.
The present invention does not have any particular limitation on the types of the flavors and colors, and conventional products well known to those skilled in the art can be used.
In the present invention, the sweetener preferably includes one or more of aspartame, stevioside, acesulfame and sugar alcohol, more preferably one or more of aspartame, stevioside and sugar alcohol. When the sweetener is more than two of the specific choices, the proportion of the specific substances is not limited in any way, and the specific substances can be mixed according to any proportion. In the present invention, the sugar alcohol is preferably one or more of sorbitol, maltitol, xylitol, isomalt, mannitol, lactitol and erythritol, and more preferably one or more of xylitol, isomalt and mannitol. When the sugar alcohol is two or more of the above specific choices, the present invention does not have any particular limitation on the ratio of the specific substances, and the specific substances may be mixed in any ratio. In the examples of the present invention, the sweetener is specifically isomalt, xylitol or mannitol and isomalt in a mass ratio of 3:1.
In the present invention, the dosage form of the antioxidant hydrogen-rich nutrient supplement is preferably a powder, a granule or a tablet, and more preferably a granule or a tablet. In an embodiment of the invention, the dosage form is in particular a tablet.
In the present invention, when the dosage form of the antioxidant hydrogen-rich nutrient supplement is a granule or a tablet, the auxiliary material preferably further includes a disintegrant and/or a lubricant.
In the present invention, when the auxiliary material includes a disintegrant, the mass percentage of the disintegrant in the auxiliary material is 0.5 to 40%, more preferably 0.5 to 20%, and most preferably 0.5 to 10%. In the present invention, the disintegrant preferably comprises one or more of dry starch, sodium carboxymethyl starch, hydroxypropyl cellulose, crospovidone, and croscarmellose sodium, and more preferably one or more of dry starch, sodium carboxymethyl starch, and hydroxypropyl cellulose. When the disintegrating agent is more than two of the above specific choices, the invention has no special limitation on the proportion of the specific substances, and the specific substances can be mixed according to any proportion. In an embodiment of the invention, the disintegrant is in particular dry starch.
In the present invention, when the auxiliary material includes a lubricant, the lubricant is 0.1 to 10% by mass of the auxiliary material, more preferably 0.1 to 8% by mass, and most preferably 0.3 to 0.6% by mass. In the present invention, the lubricant preferably includes one or more of stearic acid, magnesium stearate, calcium stearate, sodium lauryl sulfate, silica gel powder, talc, hydrogenated vegetable oil, polyethylene glycol, and magnesium lauryl sulfate, and more preferably one or more of magnesium stearate, calcium stearate, silica gel powder, and talc. When the lubricant is more than two of the above specific choices, the present invention does not have any special limitation on the proportion of the above specific substances, and the specific substances can be mixed according to any proportion. In an embodiment of the invention, the lubricant is in particular magnesium stearate or calcium stearate.
In the present invention, the tablets are preferably prepared by compression using a tablet press; the pressure of the tablet press is preferably 1-100 MPa, more preferably 5-50 MPa, and most preferably 10-30 MPa; the tabletting time is preferably 1 to 10min, more preferably 1 to 8min.
The preparation method of the antioxidant hydrogen-rich nutrient supplement powder and the antioxidant hydrogen-rich nutrient supplement granule is not limited in any way, and the method for preparing the powder and the granule which is well known to the technical personnel in the field can be adopted.
In the invention, the antioxidant hydrogen-rich nutrient element supplement can provide sufficient hydrogen for a human body and can provide metal elements required by the human body. Particularly, the antioxidant hydrogen-rich nutrient element supplement continuously generates hydrogen in the stomach, so that the problem of low hydrogen concentration of most products in the current market is solved, and an excellent antioxidant effect can be achieved; the intake of important metal nutrient elements can improve the health condition of human body while taking hydrogen.
The invention also provides application of the antioxidant hydrogen-rich nutrient element supplement in the technical scheme in the field of food or medicines.
In the invention, when the antioxidant hydrogen-rich nutrient element supplement is applied to food or medicines, the intake amount of metal in the antioxidant hydrogen-rich nutrient element supplement preferably refers to the national people's republic of China health industry standard (WS/T578.3-2017, WS/T578.2-2018).
To further illustrate the present invention, the antioxidant hydrogen-rich nutrient supplement provided by the present invention and its use are described in detail below with reference to examples, which should not be construed as limiting the scope of the present invention.
Example 1
Fully mixing 1g of magnesium powder with the granularity of 200 meshes (the screening pore size is 74 mu m), 15g of mannitol, 7g of maltodextrin, 20g of dry starch, 2g of magnesium stearate and 5g of isomaltitol, and pressing for 1min on a 10MPa tablet press to obtain 100 tablets of the antioxidant hydrogen-rich nutrient supplement tablet, wherein the mass of each tablet is about 500mg, and the mass of magnesium-containing metal is about 10mg;
10mL hydrochloric acid with the concentration of 0.1mol/L, pH value of about 1.0 is adopted to simulate gastric juice, 1 antioxidant hydrogen-rich nutrient element supplement tablet is added, the mixture is fully vibrated for 10min to simulate the digestion process, the generated hydrogen is collected by a device shown in FIG. 1 to obtain 12.0mL hydrogen, the purity is 78.4 percent through gas chromatography detection, the hydrogen amount is about 0.42mmol, and the hydrogen intake is equivalent to drinking about 500mL saturated hydrogen-rich water once. The embodiment supplements magnesium element in the range recommended by the national standard, and is beneficial to correcting electrolyte metabolism disorder.
Example 2
Fully mixing 0.9g of iron powder with a mesh size of 200 meshes (with a screening aperture of 74 mu m), 0.1g of zinc powder with a mesh size of 200 meshes (with a screening aperture of 74 mu m), 20g of alpha-cyclodextrin, 10g of maltodextrin, 7g of ascorbic acid, 10g of isomaltitol and 2g of calcium stearate, and pressing the mixture on a 10MPa tablet press for 1min to obtain 100 tablets of the antioxidant hydrogen-rich nutrient supplement, wherein the mass of each tablet is about 500mg, the mass of each tablet is about 9mg of iron metal, and the mass of the zinc metal is about 1mg;
simulating gastric juice by 10mL hydrochloric acid with the concentration of 0.1mol/L, pH value of about 1.0, adding 1 antioxidant hydrogen-rich nutrient element supplement tablet, fully shaking for 10min to simulate digestion process, collecting generated hydrogen by using a device shown in FIG. 1 to obtain 6.1mL hydrogen, wherein the purity is 65.8 percent through gas chromatography detection, the hydrogen amount is about 0.18mmol, and the hydrogen intake amount is equivalent to drinking about 220mL saturated hydrogen-rich water once. Meanwhile, the iron element, the zinc element and the ascorbic acid are taken, and the embodiment is more suitable for supplementing the iron element in the national standard recommended range, so that the anemia can be relieved.
Example 3
Fully mixing 0.1g of iron powder with 200 meshes (the screening aperture is 74 mu m), 0.9g of zinc powder with 200 meshes (the screening aperture is 74 mu m), 20g of alpha-cyclodextrin, 10g of maltodextrin, 5g of ascorbic acid, 2g of citric acid, 10g of xylitol and 2g of calcium stearate, and pressing for 1min on a 10MPa tablet press to obtain 100 tablets of the antioxidant hydrogen-rich nutrient supplement tablet, wherein the mass of each tablet is about 500mg, the iron metal is about 1mg and the zinc metal is about 9mg;
simulating gastric juice by 10mL hydrochloric acid with the concentration of 0.001mol/L, pH value of about 3.0, adding 1 antioxidant hydrogen-rich nutrient element supplement tablet, fully shaking for 10min to simulate digestion process, collecting generated hydrogen by using a device shown in FIG. 1 to obtain 5.6mL hydrogen, wherein the purity is 64.4% by gas chromatography detection, the hydrogen amount is about 0.16mmol, and the hydrogen intake amount is equivalent to about 190mL saturated hydrogen-rich water drunk once. Meanwhile, zinc element, iron element and ascorbic acid are ingested, and the embodiment is more suitable for supplementing zinc element in the recommended range of national standard, thereby being beneficial to promoting the intelligence development of children and maintaining the male reproductive health. In this example, citric acid is used as a fortifier to produce hydrogen gas even in the presence of insufficient stomach acid.
The embodiment shows that the antioxidant hydrogen-rich nutrient element supplement provided by the invention can provide sufficient hydrogen for a human body, about 0.001-3 mmol of hydrogen can be generated in a single time, which is equivalent to that 0.7-2000 mL of hydrogen-rich water is introduced once, so that the problem of low hydrogen concentration of most products in the current market is avoided, and an excellent antioxidant effect can be achieved; the intake of important metal nutrient elements can improve the health condition of human body while taking hydrogen.
Although the above embodiments have been described in detail, they are only a part of the embodiments of the present invention, not all of the embodiments, and other embodiments can be obtained without inventive step according to the embodiments, and all of the embodiments belong to the protection scope of the present invention.
Claims (10)
1. An antioxidant hydrogen-rich nutrient element supplement is characterized by comprising the following components in percentage by mass: 1 part of metal and 1-10000 parts of auxiliary materials;
the metal comprises one or more of calcium, magnesium, zinc, iron, strontium, manganese, aluminium and lithium.
2. The antioxidant hydrogen-rich nutrient supplement of claim 1, wherein the auxiliary materials comprise one or more of antioxidants, fortifiers, fillers, flavors, colors, and sweeteners.
3. The antioxidant hydrogen-rich nutrient supplement of claim 2, wherein the antioxidant comprises one or more of ascorbic acid, sodium ascorbate, and potassium ascorbate.
4. The antioxidant hydrogen-rich nutrient supplement of claim 2, wherein the fortifier comprises one or more of citric acid, malic acid, fumaric acid, succinic acid, tartaric acid, salicylic acid, gluconic acid, and amino acids.
5. The antioxidant hydrogen-rich nutrient supplement of claim 2, wherein the filler is one or more of starch, dextrin, sucrose, maltose, glucose, microcrystalline cellulose, and lactose.
6. The antioxidant hydrogen-rich nutritional supplement of any one of claims 1-5, wherein the antioxidant hydrogen-rich nutritional supplement is in the form of a powder, granule or tablet.
7. The antioxidant hydrogen-rich nutrient supplement of claim 6, wherein when the dosage form of the antioxidant hydrogen-rich nutrient supplement is a granule or a tablet, the auxiliary material further comprises a disintegrant and/or a lubricant.
8. The antioxidant hydrogen-rich nutrient supplement of claim 7, wherein the disintegrant comprises one or more of dry starch, sodium carboxymethyl starch, hydroxypropyl cellulose, crospovidone, and croscarmellose sodium.
9. The antioxidant hydrogen rich nutrient supplement of claim 7, wherein the lubricant comprises one or more of stearic acid, magnesium stearate, calcium stearate, sodium lauryl sulfate, powdered silica gel, talc, hydrogenated vegetable oils, polyethylene glycols, and magnesium lauryl sulfate.
10. Use of the antioxidant hydrogen-rich nutritional supplement of any one of claims 1-9 in the food or pharmaceutical field.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211157750.0A CN115553470A (en) | 2022-09-22 | 2022-09-22 | Antioxidant hydrogen-rich nutrient element supplement and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211157750.0A CN115553470A (en) | 2022-09-22 | 2022-09-22 | Antioxidant hydrogen-rich nutrient element supplement and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115553470A true CN115553470A (en) | 2023-01-03 |
Family
ID=84742022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211157750.0A Pending CN115553470A (en) | 2022-09-22 | 2022-09-22 | Antioxidant hydrogen-rich nutrient element supplement and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115553470A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102000109A (en) * | 2010-09-30 | 2011-04-06 | 泰山医学院 | Pharmaceutical preparation using hydrogen as therapeutic substance and preparation method thereof |
US20170209486A1 (en) * | 2017-04-06 | 2017-07-27 | Shanghai Jiao Tong University | Health-care preparation simultaneously with magnesium supplement and antioxidant functions and preparation method thereof |
CN110089590A (en) * | 2019-04-14 | 2019-08-06 | 武汉宝盈普济科技有限公司 | Application of the calcium hydrogen-rich water additive in tealeaves, milk powder, coffee or the extract of malt and milk |
CN110200991A (en) * | 2019-07-10 | 2019-09-06 | 陈天朗 | Facilitate hydrogen manufacturing product and its application for remove human body active oxygen radical |
CN110250498A (en) * | 2019-07-03 | 2019-09-20 | 浙江大学 | A kind of response of intestinal environment produces hydrogen particle and preparation method thereof |
CN114766663A (en) * | 2022-03-01 | 2022-07-22 | 霍永强 | Food material with comprehensive conditioning effect and preparation method thereof |
-
2022
- 2022-09-22 CN CN202211157750.0A patent/CN115553470A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102000109A (en) * | 2010-09-30 | 2011-04-06 | 泰山医学院 | Pharmaceutical preparation using hydrogen as therapeutic substance and preparation method thereof |
US20170209486A1 (en) * | 2017-04-06 | 2017-07-27 | Shanghai Jiao Tong University | Health-care preparation simultaneously with magnesium supplement and antioxidant functions and preparation method thereof |
CN110089590A (en) * | 2019-04-14 | 2019-08-06 | 武汉宝盈普济科技有限公司 | Application of the calcium hydrogen-rich water additive in tealeaves, milk powder, coffee or the extract of malt and milk |
CN110250498A (en) * | 2019-07-03 | 2019-09-20 | 浙江大学 | A kind of response of intestinal environment produces hydrogen particle and preparation method thereof |
CN110200991A (en) * | 2019-07-10 | 2019-09-06 | 陈天朗 | Facilitate hydrogen manufacturing product and its application for remove human body active oxygen radical |
CN114766663A (en) * | 2022-03-01 | 2022-07-22 | 霍永强 | Food material with comprehensive conditioning effect and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
苏军凯;李佩;刘妍;邓立新;温春虹;张鸣青;: "不同给药途径的外源性氢气制备方法", 医疗装备, no. 04, pages 25 - 26 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5455235A (en) | Food composition for inhibiting the formation of an intestinal putrefactive product | |
CN103141787B (en) | Acerola cherry preparation and preparation method thereof | |
CN107929313B (en) | Natural oyster calcium carbonate preparation for preventing and treating calcium deficiency and preparation method thereof | |
JPH05344873A (en) | Preparation of water-soluble extract of ginkgo leaf | |
KR102618441B1 (en) | Composition for producing hydrogen rich water and other products | |
US20160375073A1 (en) | Composition for treatment or prevention of obesity, containing water extracts of fomitella fraxinea | |
CN111631403B (en) | Vitamin C effervescent tablet and preparation method thereof | |
CN112741840A (en) | B-vitamin dietary fiber effervescent tablet and preparation method thereof | |
CN115553470A (en) | Antioxidant hydrogen-rich nutrient element supplement and application thereof | |
JP2789069B2 (en) | Intestinal putrefaction product production beverage composition | |
CN107361282A (en) | A kind of vitamin C E effervescent tablets and preparation method thereof | |
CN111617042A (en) | Composite calcium carbonate vitamin D3Water-free swallow granule and preparation method thereof | |
JP2013116099A (en) | Solid composition | |
JP6608217B2 (en) | Solid composition | |
JP5917078B2 (en) | Solid composition | |
CN113100320B (en) | Walnut oligopeptide candy with function of relieving sub-health fatigue and preparation method thereof | |
CN104126806A (en) | Vitamin B12 sublingual tablet and preparation method thereof | |
JP2008074734A (en) | Ameliorating agent for insulin resistance | |
CN102511715A (en) | Momordica grosvenori effervescent tablets and preparation process thereof | |
JP2596509B2 (en) | Novel glucuronic acid-containing oligosaccharide, production method thereof and use thereof | |
KR101389955B1 (en) | Preparation method of coated tablet having body fat reducing function | |
CN110663857A (en) | Green radish flavor dietary fiber effervescent powder and preparation method thereof | |
CN110074306A (en) | A kind of inulin solid beverage and preparation method thereof | |
JP2986133B2 (en) | Mineral absorption enhancer | |
KR20150119753A (en) | Composition for health foods of jelly type comprising aloe polysaccharide as an active ingredient and the method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |